Cited by 694SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesCOVID-19 Clinical Research Studies

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020

Open access

Leung, Kathy, Shum, Marcus HH, Leung, Gabriel M, Lam, Tommy TY, Wu, Joseph T·2021·Eurosurveillance

DOI 10.2807/1560-7917.es.2020.26.1.2002106PMC PMC7791602

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

Two new SARS-CoV-2 lineages with the N501Y mutation in the receptor-binding domain of the spike protein spread rapidly in the United Kingdom. We estimated that the earlier 501Y lineage without amino acid deletion Δ69/Δ70, circulating mainly between early September and mid-November, was 10% (6–13%) more transmissible than the 501N lineage, and the 501Y lineage with amino acid deletion Δ69/Δ70, circulating since late September, was 75% (70–80%) more transmissible than the 501N lineage.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2807/1560-7917.es.2020.26.1.2002106

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Phylogeny of SARS-CoV-2 showing the emergence of 501Y lineages, United Kingdom and other regions, as at 19 December 2020CC BY · PubMed Central

Figure 2 Observed daily number and weekly proportion of SARS-CoV-2 501N, 501Y Variant 1 and 501Y Variant 2a sequences during their co-circulation, by dates of sampling, (A) United Kingdom, (B) England, (C) Wales, (D) Scotland and Northern Ireland, 22 September–1 December 2020CC BY · PubMed Central

Figure 3 Observed and fitted proportion of SARS-CoV-2 (A) 501Y Variant 1 and (B) 501Y Variant 2a sequences during their co-circulation with SARS-CoV-2 501N, United Kingdom, 22 September–16 November 2020CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments
Price, M. N., Dehal, P. S., & Arkin, A. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009490 · Cited by 14,894
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Rambaut, A., Holmes, E. C., O’Toole, Á., Hill, V., McCrone, J. T., Ruis, C., du Plessis, L., & Pybus, O. G. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0770-5 · Cited by 2,543
Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa
Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E. J., Msomi, N., et al. (2020) · doi:10.1101/2020.12.21.20248640 · Cited by 2,535
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.012 · Cited by 1,956
SARS-CoV-2 evolution during treatment of chronic infection
Kemp, S. A., Collier, D. A., Datir, R. P., Ferreira, I. A. T. M., Gayed, S., Jahun, A., Hosmillo, M., Rees-Spear, C., Mlcochova, P., Lumb, I. U., et al. (2021) · Nature · doi:10.1038/s41586-021-03291-y · Cited by 1,097
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.020 · Cited by 1,006
First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment
Leung, K. S. M., Wu, J. T. K., Liu, D., & Leung, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30746-7 · Cited by 840
Self-citation
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptationPreprint
Kemp, S. A., Collier, D. A., Datir, R. P., et al. (2020) · medRxiv · doi:10.1101/2020.12.05.20241927 · Cited by 180
Nasal ACE2 Levels and COVID-19 in Children
Patel, A. B., & Verma, A. (2020) · JAMA · doi:10.1001/jama.2020.8946 · Cited by 143

Show all 12 references

Research works printed but not linked: 1

Kemp, 2020, Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/ΔV70, bioRxiv

Sorted by citations

Items 601–691 of 691

UM DIÁLOGO ENTRE TÊMIS E HIGÉIA: PENSAR OS OBSTÁCULOS EMERGENTES NA PROMOÇÃO DO DIREITO À SAÚDE EM TEMPOS DE PANDEMIA DA COVID-19 NO CENÁRIO BRASILEIRO
Rangel, T. L. V., Curcio, F. S., & da Costa, H. M. V. (2021) · doi:10.22533/at.ed.3072104114
[Anthralin erythema: effect of concentration, contact time, oxidation products and corticosteroids. Clinical, reflection photometry and electron microscopy studies].
Puschmann, M. (1983) · PubMed
Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli Venezia Giulia
Mio, C., Secco, C. D., Marzinotto, S., Bruno, C., Pimpo, S., Betto, E., Bertoni, M., Pipan, C., Sozio, E., Tascini, C., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261229
“angiotensin-converting enzyme 2 (ACE2) receptor [18] and an increased transmissibility compared to previous circulating SARS-CoV-2 lineages [19].”
Background
S Gene Target Failure (SGTF) in Commercial Multiplex RT-PCR assay as indicator to detect SARS-CoV-2 VOC B.1.1.7 lineage in Tamil Nadu, IndiaPreprint
Vidya, N., Kumaresan, A., Kalaivani, V., Kumar, A., Gurunathan, S., Selvi, R. A., Uma, R., Varsha, P., Raju, S., Sampath, P., et al. (2021) · medRxiv · doi:10.1101/2021.12.14.21251883
“Thus, substantiating increased transmissibility of this variant among the population (Leung et al., 2021).”
Background
Estimating the transmissibility of SARS-CoV-2 VOC 202012/01 in Japan using travel history information
Kayano, T., & Nishiura, H. (2022) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2022125
An expanded high throughput RT-PCR assay to rapidly identify all known SARS-CoV-2 variants of concern using melting temperature codingPreprint
Banada, P. P., Green, R., Banik, S., Streck, D. L., Montalvan, I., Reiss, R., Jones, R., Marras, S. A. E., Chakravorty, S., & Alland, D. (2022) · medRxiv · doi:10.1101/2022.01.18.22269424
Neurologische Komplikationen bei COVID-19-Infektion
Gülke, E., & Gerloff, C. P. (2022) · Neuroradiologie Scan · doi:10.1055/a-1678-3250
Initial Proportion and Dynamic of B.1.1.7 SARS-CoV-2 in a Large City in the West of Germany
Herkenrath, S. D., Boschung, K., Nacov, J. A., Heibges, A., Schroer, B., Treml, M., & Randerath, W. J. (2022) · Biomedicine Hub · doi:10.1159/000519968
Rapid screening assays of N501Y and E484K SARS-CoV-2 variants and identification of an emerging N501T variant in FrancePreprint
François, C., Descamps, V., Combremont, A.-G., Morel, V., Brochot, É., Demey, B., & Castelain, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1404648/v1
Validation of a simplified comorbidity evaluation predicting clinical outcomes among patients with coronavirus disease 2019 – A multicenter retrospective observation study
d’Etienne, J. P., Alanis, N., Chou, E. H.-C., Garrett, J. S., Kirby, J. J., Bryant, D. P., Shaikh, S., Schrader, C. D., & Wang, H. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.03.011
nSARS-CoV-2 and COVID-19 Pandemic: From Emergence to Vaccination
Shahid, I. (2022) · Dr Sulaiman Al Habib Medical Journal · doi:10.1007/s44229-022-00006-x
“, N501Y) increases the affinity of the virus to the receptor-binding domain (RBD) of ACE2 [28] (Table 1).”
BackgroundInfluential
Peer Review #1 of "Genomic analysis of early transmissibility assessment of the D614G mutant strain of SARS-CoV-2 in travelers returning to Taiwan from the United States of America (v0.2)"
(2021) · PeerJ · doi:10.7287/peerj.11991v0.2/reviews/1
A Rapid and Consistent Method To Identify SARS-CoV-2 Variants By RT-PCRPreprint
Fabiani, M., Margiotti, K., Sabatino, M., Viola, A., Mesoraca, A., & Giorlandino, C. (2021) · Research Square · doi:10.21203/rs.3.rs-521517/v2
Peer Review #3 of "Genomic analysis of early transmissibility assessment of the D614G mutant strain of SARS-CoV-2 in travelers returning to Taiwan from the United States of America (v0.1)"
(2021) · PeerJ · doi:10.7287/peerj.11991v0.1/reviews/3
Volume 42 Number 1
(2021) · Microbiology Australia · doi:10.1071/mav42n1
Peer Review #1 of "Genomic analysis of early transmissibility assessment of the D614G mutant strain of SARS-CoV-2 in travelers returning to Taiwan from the United States of America (v0.1)"
(2021) · PeerJ · doi:10.7287/peerj.11991v0.1/reviews/1
Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variantsPreprint
Ferdous, N., Reza, M. N., Islam, M. S., Emon, M. T. H., NASSAN, M. A., Ahmed, E. I., Batiha, G. E., Mohiuddin, A. K. M., & Hossain, M. U. (2021) · Research Square · doi:10.21203/rs.3.rs-515155/v1
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS TYPE 2 OMICRON VARIANT OUTBREAK IN INDIA: TIME TO ALERT
Nagarajan, P., KUMAR, J., Howlader, A., Sabapathy, S. K., GOPAL, M., Louis, L. R. P., & KUMAR, S. (2022) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2022.v15i6.44731
South African (501Y.V2) and the United Kingdom (B.1.1.7) SARS-CoV-2 Spike (S) Protein Variants Demonstrate a Higher Binding Affinity to ACE2
Mohammad, A., Al‐Mulla, F., & Abubaker, J. A. (2022) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207325666220607145225
Diagnostica molecolare di precisione: un'unica strategia per rilevare SARS-CoV-2 e il lineage B.1.1.7
TRINCHESE, G., MARTINO, M. C. D., & Saraiello, A. (2022) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.23736/s1825-859x.22.00145-1
The Evolution of SARS-CoV-2
Bailey, S. F., & Akter, M. (2022) · Springer eBooks · doi:10.1007/978-981-19-1356-3_5
Molecular dynamic simulation suggests stronger in-silico docking of Omicron spike on ACE2 than Wild but weaker than Delta SARS-CoV-2 variants can be blocked by engineered S1-RBD fractionPreprint
Santra, D., & Maiti, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1451089/v1
Strain Variation Based on Spike Glycoprotein Gene of SARS-CoV-2 in Kuwait from 2020 to 2021
Madi, N., Sadeq, M., Essa, S. S., Safar, H. A., Al‐Adwani, A., & Al-Khabbaz, M. (2022) · Pathogens · doi:10.3390/pathogens11090985
Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against OmicronPreprint
Chi, X., Xia, L., Zhang, G., Chi, X., Huang, B., Zhang, Y., Chen, Z., Han, J., Wu, L., Li, Z., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.25.509344
SARS-CoV-2 Vaccine Against Virus: Mission Accomplished!?
Magnus, C. L., & Schmidt, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-08045-6_27
Perspective Chapter: Real-Time Genomic Surveillance for SARS-CoV-2 on Center Stage
Paz, M., Moreno, P., & Moratorio, G. (2022) · Infectious diseases · doi:10.5772/intechopen.107842
Overview and Recommendations on Worrying SARS-CoV-2 Virus Variants (VOC)
Shneine, J. K., & Ahmad, S. M. (2022) · Journal of Al-Nahrain University-Science · doi:10.22401/anjs.25.3.09
A Comprehensive Review on Covid-19 Variants
Asra, S., Anusha, C. V., Ahalya, M. T., Rehman, A., & Suman, P. (2022) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2022.47073
Current Status of Vaccines Developed for SARS-CoV-2 Infection: A Review
Hoyos, C. A. M., Sánchez, J. P. C., Gómez, R. F., & Vivas, M. C. (2022) · Bangladesh Journal of Infectious Diseases · doi:10.3329/bjid.v9i9.62614 · Cited by 1
Studies on the enzymatic specificity of diguanylate cyclases domains and the production of new second messengers
Arévalo, S. J. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2022.tde-26102022-112347
Infectivity, Morbidity, Emerged Variants of SARS-CoV-2 and Vaccination in Indian Perspectives from First Wave to Second Wave of COVID-19
(2022) · Letters in Applied NanoBioScience · doi:10.33263/lianbs123.087
Clinical and laboratory features of COVID-19 patients infected with SARS-CoV-2 variant B.1.1.7 versus those infected with other SARS-CoV-2 strains
Ergenç, Z., Ergenç, H., Öztürk, A., Kaya, G., Ocak, Ö. K., & İnce, Ö. (2022) · Journal of Acute Disease · doi:10.4103/2221-6189.362815
Epidemiological study and health management of an imported incident of COVID–19 asymptomatic cases in Haikou, China
Zhang, F., Lin, G., Jin, Y., Wu, T., Chen, J., Fan, L.-C., Lv, Z., & Xiang, W. (2022) · One Health Bulletin · doi:10.4103/2773-0344.361971
Pathogenesis of Breakthrough Infections with SARS-CoV-2 Variants in Syrian HamstersPreprint
Plunkard, J., Mulka, K. R., Zhou, R.-F., Tarwater, P., Zhong, W., Lowman, M., Wong, A., Pekosz, A., & Villano, J. (2023) · bioRxiv · doi:10.1101/2023.01.12.523876
“3 is genetically similar to the originally circulating virus with minimal mutations, 252 and the groups that exhibited relatively less weight loss were infected with variants possessing 253 multiple mutations known to affect viral fusogenicity and infectivity (1, 15, 21, 22).”
Background
"Can the Following Strategy Generate a Definitive Anti-Covid Vaccine?"
Gennaro, C. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.42.006753
Ortaokul Öğrencilerinin Biyoteknoloji ve Biyogüvenlik Konularına Yönelik Etik Görüşlerinin İncelenmesi
GÖCÜK, A., & Şahin, F. (2023) · Eğitim ve Yeni Yaklaşımlar Dergisi · doi:10.52974/jena.1231510
SARS-CoV-2: Structure, Pathogenesis, and Diagnosis
Goverdhan, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87539-4.00002-6
PERFIL EPIDEMIOLÓGICO E SOCIODEMOGRÁFICO DA TUBERCULOSE NO ESTADO DO PIAUÍ: UMA ANÁLISE DE DUAS DÉCADAS
de Carvalho, F. R., dos Santos, S. L., Silva, L. D. C., dos Santos, A. D., Gomes, M. L., & Júnior, C. P. D. S. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c21
ENFERMEIRA NOS TRÂMITES DA DOAÇÃO E CAPTAÇÃO DE ÓRGÃOS DE UM POTENCIAL DOADOR COM MORTE ENCEFÁLICA
Fernandes, L. N. D. S., Pedro, I. S. D. S., dos Santos, A. V., & Paranhos, J. O. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c20
VIRTOPSIA NO DIAS ATUAIS: VANTAGENS E DESVANTAGENS
Bandeira, G. B. D. S., & Taumaturgo, I. D. C. B. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c23
ALIMENTAÇÃO SAUDÁVEL: DETERMINANTES SOCIODEMOGRAFICOS E ECONÔMICOS DE IDOSOS ASSISTIDOS EM PROGRAMA DE EXTENSÃO UNIVERSITÁRIA
Ferreira, P. L. A., Gama, S. M. B. D. C., de Lima, S. Y. V., Araújo, Y. E. L., Moreira, L. R. L. F., dos Santos, S. L., Teixeira, M. R. M., Estevão, A. B., Lapa, R. C., & Alencar, M. D. S. S. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c9
PAPEL DO ENFERMEIRO NA ATENÇÃO PRIMÁRIA NO ATENDIMENTO A PACIENTES COM TRANSTORNOS MENTAIS LEVES
Oliveira, A. P. S. D. S., Sena, C. C., Souza, S. L. D. S., & Ribeiro, A. M. V. B. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c5
CAPACITAÇÃO DO ENFERMEIRO EM SITUAÇÕES DE URGÊNCIA E EMERGÊNCIA NA ATENÇÃO PRIMÁRIA A SAÚDE: REVISÃO INTEGRATIVA
Ferreira, J. C., Rodrigues, M. I. R., & dos Santos, S. L. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c16
A IMPORTÂNCIA DO CUIDADO PSICÓLOGICO HUMANIZADO NA UNIDADE DE TERAPIA INTENSIVA (UTI)
Gomes, M. L., Júnior, C. P. D. S., de Carvalho, F. R., dos Santos, S. L., Silva, L. D. C., & dos Santos, A. D. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c19
DIAGNÓSTICO E TRATAMENTO DA ANEMIA FALCIFORME: uma revisão literatura
de Oliveira, L. F. C., Rosa, M. A. S., Pereira, R. D. S., & Ribeiro, A. M. V. B. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c2
CONHECIMENTO DE IDOSOS SOBRE SEXUALIDADE: UMA REVISÃO INTEGRATIVA
de Araújo, G. S. S., Rodrigues, A. S., Lopes, P. F., Silva, S. B. C. B., & de Gois, L. C. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c12
PROPOSTA DE DESENVOLVIMENTO DE PRODUTO PARA ACESSIBILIDADE DE PESSOAS SURDAS NOS EXAMES DE TOMOGRAFIA COMPUTADORIZADA
Silveira, T. M., & Taumaturgo, I. D. C. B. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c25
ATUAÇÃO DA FISIOTERAPIA EM PACIENTES COM DOR CERVICAL: REVISÃO INTEGRATIVA DE LITERATURA
Sousa, D. L., Cruz, H., Silva, E. F. N., da Silva, L. R., Miranda, É. T. F., de Sousa, H. R. L., Viana, Y. C. G., Nascimento, L. V. S., Silva, B. F. S., & de Carvalho, F. R. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c7
ANÁLISE DE FATORES DE RISCO ASSOCIADOS A MORTALIDADE POR COVID 19 NO ALTO SERTÃO DA PARAIBA
Nascimento, S. G. D. S., & de Sousa, R. P. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c14
A FALTA DE ADESÃO AS VACINAS E O SEU IMPACTO NA SAÚDE DA POPULAÇÃO BRASILEIRA
de Souza, L. E. S., Faust, A. J., Westphal, L., de Vasconcelos, A. C., Toss, A. F. D. O., da Silva, A. P., Chaves, M. F. D. M., da Silva, A. M. S., de Oliveira, I. M. R., & Filho, M. A. R. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c6
ANÁLISE DA QUALIDADE DE VIDA E FUNCIONALIDADE EM PACIENTES COM OSTEOARTROSE DE JOELHO
Sousa, D. L., Cruz, H., Silva, E. F. N., da Silva, L. R., Miranda, É. T. F., de Sousa, H. R. L., Viana, Y. C. G., Nascimento, L. V. S., Silva, B. F. S., & de Carvalho, F. R. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c1
PERFIL DA REALIZAÇÃO DE EXAME MAMOGRÁFICOS ENTRE OS ANOS DE 2019 – 2022: INFLUENCIA DA PANDEMIA COVID-19 NA DETECÇÃO PRIMÁRIA DO CÂNCER DE MAMA
de Sousa, F. A., & Taumaturgo, I. D. C. B. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c13
FATORES PREDISPONENTES E PROFILAXIA PARA TROMBOEMBOLISMO EM PACIENTES IDOSOS
Carvalho, K. L., Oliveira, A. C. S. R., Rodrigues, F. T., Fernandes, D. J., dos Santos, M. R., & Rocha, C. A. G. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c22
PREVENÇÃO DAS PRINCIPAIS DOENÇAS QUE ACOMETE A SAÚDE DAS MULHERES
de Souza, L. E. S., Pinto, V. B., Luiz, D. D. S., da Silva, M. C. M. F. C., Toss, A. F. D. O., da Silva, A. P., Chaves, M. F. D. M., da Silva, A. M. S., de Oliveira, R. D. V. C., & de Oliveira, I. M. R. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c10
RELEVÂNCIA DA PARTICIPAÇÃO DE ESTUDANTES DO CURSO TÉCNICO DE ENFERMAGEM EM CAMPANHAS DE IMUNIZAÇÃO CONTRA INFLUENZA
Paiva, J. D. S., Pezzi, S. A., Lima, A. M. A. O., Costa, E. C., Nogueira, M. R. D. N., da Silva, D. P., Paiva, A. C. M., Oliveira, A. C. S. R., & Queiroz, T. A. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c8
OBSTRUÇÃO DAS VIAS AERÉAS POR CORPO ESTRANHO (OVACE): EDUCAÇÃO PERMANENTE DOS PROFISSIONAIS NA ATENÇÃO PRIMÁRIA À SAÚDE
Gonçalves, M. R., Dantas, F. W. D. L., de Oliveira, M. J. P., da Costa, R. J., de Oliveira, J. J., Ferreira, T. D. D. S., & Bezerra, Y. C. P. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c17
INTERVENÇÕES FISIOTERAPÊUTICAS EM INDIVÍDUOS HOSPITALIZADOS DIANTE DE UMA UNIDADE DE TERAPIA INTENSIVA
Gonçalves, I. B., & da Silva, E. P. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c11
BENEFÍCIOS DO USO DA TERAPIA DE BAIXO E ALTO CALOR: PONTO DE VISTA DA ENFERMAGEM
Dantas, F. W. D. L., Gonçalves, M. R., de Sousa, H. R. A., da Silva, C. P., da Silva, E. P., Sarmento, J. L. D. C., & Braga, T. R. O. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c18
PERCEPÇÃO DO SOFRIMENTO DE ALUNOS DE MESTRADO PROFISSIONAL DURANTE O PROCESSO DE APRENDIZAGEM DE UMA UNIVERSIDADE
de Fontes-Junior, A. A. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c24
VACINA CONTRA O PAPILOMAVÍRUS HUMANO: UM PROBLEMA DE SAÚDE PÚBLICA
Lucena, J. R. J., Faust, A. J., Adão, M. B., de Araújo, L. C. S., Silva, M. E. D. A., Rocha, C. A. G., dos Santos, J. G., & de Lima, A. O. F. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c15
IMPACTOS DA PANDEMIA DO COVID-19 À SAUDE MENTAL DAS ENFERMEIRAS
Capinan, H. S., Cichovicz, P. M., Ribeiro, A. M. V. B., & dos Santos, N. V. C. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230420c4
COVID-19
Juhas, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-29544-7_10
Insights from a 3-Year Genomic Evolution of SARS-CoV-2 Shows a Predominance of Variants from Developing CountriesPreprint
Essabbar, A., Mazouri, S. E., & Ibrahimi, A. (2023) · Research Square · doi:10.21203/rs.3.rs-2736612/v2
Molecular insights into the binding interactions and energetics of the omicron spike variant with hACE2 and a neutralizing antibody
Kumar, V., Shefrin, S., & Sundar, D. (2024) · Journal of Structural Biology · doi:10.1016/j.jsb.2024.108087
Effect of Long-Distance Domestic Travel Ban Policies in Japan on COVID-19 Outbreak Dynamics During Dominance of the Ancestral Strain: Ex Post Facto Retrospective Observation Study
Kurita, J., & Iwasaki, Y. (2024) · Online Journal of Public Health Informatics · doi:10.2196/44931
“The infectiousness of the Alpha variant was estimated to be 35%-90% higher than that of the ancestral strain [28-31].”
Background
Studies with Vaccination and Asymptomatic Transmission Models
吉, 彦. (2024) · Pure Mathematics · doi:10.12677/pm.2024.145197
Different variants of SARS-CoV-2
Samanta, A., Hassan, M. S., Nasrin, T., Alam, S. S. M., Jamil, Z., Buttar, H. S., Ali, S., & Hoque, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95650-5.00053-7
Bridging the Sequencing Gap: N501Y SNP RT-qPCR Assay Detects First SARS-CoV-2 Beta Variant in the PhilippinesPreprint
Bado, S. L. P., Galap, N. B., Manalo, J. I. G., Onza, O. J. T., Pelingon, M. R. B., Parayray, J. M. L., Palciso, J. M., Tomas, K. I. C., Abulencia, M. F. B., Polotan, F. G. M., et al. (2024) · medRxiv · doi:10.1101/2024.06.26.24309150
Epidemiology and Prognosis of COVID-19 Patients in the First to Third Waves of the Epidemic in Southern Fars Province, Iran
Zahedi, R., Chegeni‬‬, M., & Rahmanian, V. (2023) · Taḥqīq va tusi̒ah-i salāmata · doi:10.61186/jhrd.1.1.1
Coronaviruses
Mostafa, H. H., & Pinsky, B. A. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0093
Advancements in Structural Basis of Covalent Inhibitors Targeting SARS-CoV-2 Essential Proteins
Fatima, I., Alshabrmi, F. M., Alkhayl, F. F. A., Qasim, M., Shafqat, A., Batool, S., Jawad, M. T., Qamar, M. T. U., & Rehman, A. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673323348241208080419
Coronaviruses
Mostafa, H. H., & Pinsky, B. A. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0093
Afobazole: a potential drug candidate which can inhibit SARS CoV-2 and mimicry of the human respiratory pacemaker protein
Dabburu, G. R., Garg, A., Singhal, N., & Kumar, M. (2025) · In Silico Pharmacology · doi:10.1007/s40203-025-00316-6
“Moreover, mutations in the S protein compromise the neutralizing functions of the therapeutic antibodies and also in the antibodies produced by the vaccinated individuals(Leung et al. 2020) (Zhang et al. 2020).”
Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2
Kondo, T., Suzuki, R., Yajima, H., Kawahara, S., Yamaya, K., Ichikawa, T., Tsujino, S., Suzuki, S., Tamura, T., Hashiguchi, T., et al. (2025) · Journal of Virology · doi:10.1128/jvi.00543-25 · Cited by 1
“One of the main differences between SARS-CoV-2 VOCs/VOIs is the amino acid mutations in the spike protein, which can potentially alter host tropism (5, 6).”
SARS-CoV-2 Omicron: Genotyping, Mutational Analysis, and Characterization of Subvariants in Iran
Roozbehani, M., Keyvani, H., Tabibzadeh, A., Bokharaei‐Salim, F., & Mousavizadeh, L. (2025) · Infection Epidemiology and Microbiology · doi:10.61186/iem.11.2.123
HUBUNGAN USIA DAN JENIS KELAMIN DENGAN HASIL PEMERIKSAAN S-GENE TARGET FAILURE (SGTF) DI LABORATORIUM MIKROBIOLOGI RUMAH SAKIT UNIVERSITAS TANJUNGPURA PONTIANAK
Fathurrahman, I., Novianry, V., & Liana, D. F. (2025) · INNOVATIVE Journal Of Social Science Research · doi:10.31004/innovative.v5i3.19570
A comprehensive review of novel coronavirus disease 2019 (nCOVID-19) characteristics, diagnosis, treatment, and prevention
Mohsenzadeh, A., Pourasgar, S., Borji, S., Bavari, S., Moghadam, E. E., Tanha, H. R., Mohsenzadeh, H., Kamali, K., Moghadam, Z. B., & Sabati, H. (2022) · Journal of Current Biomedical Reports · doi:10.61186/jcbior.3.3.172
Voici pourquoi les nouveaux variants de la Covid-19 se répandent dans le monde entier
Otto, S. P. (2021) · The Conversation · doi:10.64628/aap.3vjqd3crv
Genomic Evolution of SARS-CoV-2 Variants of Concern Under In Vitro Neutralising Selection Pressure Following Two Doses of the Pfizer-BioNTech BNT162b2 COVID-19 Vaccine
Basile, K., Agius, J. E., Fong, W., McPhie, K. A., Fennel, M., Ko, D., Heuston, L., Lam, C., Arnott, A., Chen, S. C.-A., et al. (2025) · Viruses · doi:10.3390/v17091161 · Cited by 1
In silico investigation of β-lactams as inhibitors of the spike protein receptor binding domain (RBD) of SARS-CoV-2
Bag, S. S., Baishya, H. J., & Sinha, S. (2025) · Discover Chemistry. · doi:10.1007/s44371-025-00347-0
Additional file 1 of Mathematical modelling of vaccination rollout and NPIs lifting on COVID-19 transmission with VOC: a case study in Toronto, Canada
Aruffo, E., Yuan, P., Tan, Y., Gatov, E., Moyles, I. R., Bélair, J., Watmough, J., Collier, S., Arino, J., & Zhu, H. (2022) · Figshare · doi:10.6084/m9.figshare.20324715
Additional file 1 of A risk assessment tool for resumption of research activities during the COVID-19 pandemic for field trials in low resource settings
Simkovich, S. M., Thompson, L. M., Clark, M. L., Balakrishnan, K. F., Bussalleu, A., Checkley, W., Clasen, T., Dávila‐Román, V. G., Díaz-Artiga, A., Dusabimana, E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14404435
Additional file 1 of Computational analysis of affinity dynamics between the variants of SARS-CoV-2 spike protein (RBD) and human ACE-2 receptor
Sultana, N., Nagesha, S. N., Reddy, C. N. L., Ramesh, B. N., Shyamalamma, S., Shashidhara, K. S., Satish, K. M., Pradeep, C., & Vidyadhar, G. D. (2024) · Figshare · doi:10.6084/m9.figshare.26709110
Additional file 1 of Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study
Martin‐Blondel, G., Lescure, F.-X., Assoumou, L., Charpentier, C., Chapplain, J.-M., Perpoint, T., Grouteau, G., Cordel, H., Pialoux, G., Pacanowski, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20064829
Additional file 1 of No indication for SARS-CoV-2 transmission to pet ferrets, in five cities in Poland, 2021 - antibody testing among ferrets living with owners infected with SARS-CoV-2 or free of infection
Kaczorek‐Łukowska, E., Wernike, K., Beer, M., Blank, A., Małaczewska, J., Blank, M., Jałonicka, A., & Siwicki, A. K. (2023) · Figshare · doi:10.6084/m9.figshare.22599416
Impact of Listeria monocytogenes on microglia and cerebral homeostasis
Levallois, S. (2023) · theses.fr (ABES) · doi:10.70675/cf058269z5911z4582z94fezcb6761f74ddd
Epidémiologie génomique des pathogènes au Sénégal : mycobacterium tuberculosis et SARS-CoV-2
Padane, A. (2023) · theses.fr (ABES) · doi:10.70675/e6b26f76z05baz4f66z9706zbde0e41a2626
Etude phénotypique des variants du SARS-CoV-2 et de leur sensibilité aux anticorps neutralisants et monoclonaux
Boschi, C. (2022) · theses.fr (ABES) · doi:10.70675/2523e81cz0815z4a31za5cczaee28bce546b
Réponse et préparation à l'émergence des maladies virales : Thérapeutiques antivirales contre la COVID-19 et développement vaccinal contre l'encéphalite à tiques
Cochin, M. (2023) · theses.fr (ABES) · doi:10.70675/276a93a0z0301z44f4z83e9z2fffe81648e8
Nanobodies targeting SARS-CoV-2 variants
Roy, A., Yang, Y., & Du, L. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.017
Hydrophobic remodeling of the SARS-CoV-2 RBD large loop attenuates ACE2 engagement and viral fitness
Wang, A., Guo, H., Yang, H., Chen, H., Imojara, A., Ju, B., Zhang, Z., & Yan, R. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014742

Authors: Leung, K., Shum, M. H., Leung, G. M., Lam, T. T., & Wu, J. T.
Affiliations: Laboratory of Data Discovery for Health (HK)
Joint Institute of Virology (Shantou University and The University of Hong Kong), Guangdong-Hongkong Joint Laboratory of Emerging Infectious Diseases, Shantou University, Shantou, China
Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, New Territories, Hong Kong SAR, China
Corresponding author: Wu, Joseph T
ORCID: Leung, Kathy
Leung, Gabriel M
Lam, Tommy TY
Wu, Joseph T
Venue: Eurosurveillance
Publisher: European Centre for Disease Control and Prevention (ECDC)
Published: 2021-01-07
Volume: 26
Issue: 1
ISSN: 1025-496X (ISSN-L)
1560-7917
DOI: 10.2807/1560-7917.es.2020.26.1.2002106
PMC: PMC7791602
OpenAlex: W3120079728
Cited by: 694
References: 12
Citations by year: 2026: 3 · 2025: 14 · 2024: 24 · 2023: 90 · 2022: 176 · 2021: 385
FWCI: 53.29
Type: journal article
Language: en
Update notices: addendum (2021-01-21)
Open access: diamond
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: Eurosurveillance (publishedVersion, cc-by)
medRxiv (acceptedVersion, cc-by-nc-nd)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (31922087)
Hong Kong Government
Health and Medical Research Fund
Young Scientists Fund
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords: SARS-CoV-2, N501Y mutation, spike protein receptor-binding domain, viral transmissibility, United Kingdom, COVID-19 pandemic
MeSH terms: COVID-19, SARS-CoV-2, Genetic Markers, United Kingdom, Humans, Mutation, Phylogeny, Genetic Variation, Genome, Viral, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks